The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® proudly announce four recipients for the 2025 NCCN Foundation Young Investigator Awards (YIA). These awards provide ...

Each year, the Christodoula March stands as a historic symbol of solidarity with those navigating cancer. An event offering ...

New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected ...

The Manipal Academy of Higher Education (MAHE) in co-ordination with air condition department successfully hosted the third season of the Spandana Trophy, a tennis ball cricket and throwball ...

Medical oncology is a type of medicine that focuses on the diagnosis, treatment, and prevention of cancer. A medical oncologist’s job is to take care of cancer patients by using things like ...

If you have cancer, you might see a doctor who specializes in radiation oncology. It's an area of medicine that uses "radiation therapy" -- a treatment that focuses high-energy waves on your body ...

Elevation Oncology shares halted from trading in premarket trading Thursday after it said it will launch strategic options process and lay off the majority of its staff to extend its cash runway.

Predictive Oncology sells Skyline Medical's assets to DeRoyal Industries, enhancing healthcare waste management and focusing on AI-driven drug discovery. Predictive Oncology Inc. has completed the ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Artificial Intelligence (AI) and Machine Learning (ML) play a pivotal role in precision oncology, analyzing vast datasets, identifying patterns and aiding in informed decision-making. Within this ...

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States.

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncology Servier will develop and commercialize BDTX-4933, a Phase 1 asset ...